Comparing Esterified Estrogens / Methyltestosterone vs Estradiol
Esterified estrogens / methyltestosterone | Estradiol |
|
---|
Esterified estrogens / methyltestosterone | Estradiol |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Postmenopausal Symptoms, Menopausal Disorders, Hot Flashes. Esterified estrogens / methyltestosterone may also be used for purposes not listed in this medication guide. |
Prescription only
Estradiol is used to treat menopause symptoms, vulvar/vaginal thinning, low estrogen levels, and to prevent osteoporosis. It may also be used in the palliative treatment of breast cancer and prostate... View more |
||||||||||||||||
More about Esterified estrogens / methyltestosterone | More about Estradiol | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Esterified estrogens / methyltestosterone has an average rating of 9.1 out of 10 from a total of 36 ratings on Drugs.com. 89% of reviewers reported a positive effect, while 6% reported a negative effect. |
Estradiol has an average rating of 5.8 out of 10 from a total of 601 ratings on Drugs.com. 46% of reviewers reported a positive effect, while 37% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Esterified estrogens / methyltestosterone side effects |
View all Estradiol side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
Lower cost generic |
Lower cost generic |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
|
View all Estradiol prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Covaryx, Covaryx HS, EEMT, EEMT HS, Estratest F.S., Estratest H.S. | Alora, Climara, Delestrogen, Depo-Estradiol, Divigel, Dotti, Elestrin, Estra Pellets, Estrace, Estraderm, Estradiol Patch, Estrogel, Evamist, Femring, Lyllana, Menostar, Minivelle, Vivelle-Dot View more | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
N/A |
16 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 275 drugs are known to interact with Esterified estrogens / methyltestosterone:
|
A total of 393 drugs are known to interact with Estradiol:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | |||||||||||||||||
|
|
||||||||||||||||
First Approval Date | |||||||||||||||||
N/A |
July 23, 1975 |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
|||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.